A

s President Trump tweets yet another promise to lower drug prices, a new analysis offers an example of what can happen when the federal government negotiates with manufacturers.

During a 12-month period ended November 2015, the Veterans Choice Program, which was created by the US Department of Veterans Affairs, paid a median price of $12,500 for a month’s supply of Harvoni, a hepatitis C drug sold by Gilead Sciences. Since most patients typically are treated for two to three months, the cost was closer to $25,000 to $37,500 per person, according to the analysis in Medical Care.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I’m a Vietnam Vet and about to start this treatment I feel bad that these drugs are so inflated and we all pay the price. I may die without the drug so I thank all the taxpayers and condem the drug companies for their greed. Make a profit, but stop ripping off both sick and healthy people at the same time. As a conservative, I hate to say it, but maybe regulation is the answer.

  • Essentially therefore, the VA is “doing more [about prices] with less [ok, fewer]” – food for thought. That said, the law still has to change for Medicare to negotiate.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy